The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 1, 2026 | Ferrante Karen Jean | Director | Grant(A) | 627 | — | $0 |
| Jun 9, 2026 | Ros Matthew | Director | Grant(A) | 18K | — | $0 |
| Jun 9, 2026 | Harwin Peter Evan | Director | Grant(A) | 18K | — | $0 |
| Jun 9, 2026 | Ferrante Karen Jean | Director | Grant(A) | 18K | — | $0 |
| Jun 9, 2026 | Cain Christopher W. | Director | Grant(A) | 18K | — | $0 |
| Jun 9, 2026 | Shegog Todd | Director | Grant(A) | 18K | — | $0 |
| Jun 9, 2026 | Morris Arlene | Director | Grant(A) | 18K | — | $0 |
| May 19, 2026 | Robbins Andrew R | President and CEO, Director | Gift(G) | 160K | — | $0 |
| May 19, 2026 | Robbins Andrew R | President and CEO, Director | Gift(G) | 160K | — | $0 |
| Apr 1, 2026 | Ferrante Karen Jean | Director | Grant(A) | 686 | — | $0 |
| Mar 31, 2026 | Fairmount Funds Management LLC | Director | Conversion(C) | 7.0M | — | — |
| Mar 31, 2026 | Fairmount Funds Management LLC | Director | Sell(S) | 7.0M | $34.66 | $242.6M |
| Mar 31, 2026 | Fairmount Funds Management LLC | Director | Conversion(C) | 28K | — | $0 |
| Jan 22, 2026 | Fairmount Funds Management LLC | Director | Sell(S) | 3.5M | $36.40 | $127.4M |
| Jan 1, 2026 | Ferrante Karen Jean | Director | Grant(A) | 643 | — | $0 |
| Dec 26, 2025 | Robinson John Edward | Chief Scientific Officer | Sell(S) | 90K | $38.74 | $3.5M |
| Dec 26, 2025 | Sachs Jessica | Chief Medical Officer | Sell(S) | 83K | $38.70 | $3.2M |
| Dec 26, 2025 | Green John L. | Chief Financial Officer | Sell(S) | 77K | $38.68 | $3.0M |
| Dec 26, 2025 | Kearns Evan | Chief Legal Officer | Sell(S) | 65K | $38.70 | $2.5M |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | Tax withholding(F) | 145K | $39.45 | $5.7M |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | Grant(A) | 50K | — | $0 |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Dec 17, 2025 | Green John L. | Chief Financial Officer | Grant(A) | 65K | — | $0 |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | Grant(A) | 40K | — | $0 |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | Grant(A) | 260K | — | $0 |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | Tax withholding(F) | 126K | $39.45 | $5.0M |
| Dec 17, 2025 | Kearns Evan | Chief Legal Officer | Grant(A) | 55K | — | $0 |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | Tax withholding(F) | 155K | $39.45 | $6.1M |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | Grant(A) | 320K | — | $0 |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | Grant(A) | 50K | — | $0 |
| Dec 17, 2025 | Sachs Jessica | Chief Medical Officer | Grant(A) | 65K | — | $0 |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | Grant(A) | 214K | — | $0 |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | Tax withholding(F) | 95K | $39.45 | $3.7M |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | Grant(A) | 50K | — | $0 |
| Dec 17, 2025 | Pinnow Cole | Chief Commercial Officer | Grant(A) | 65K | — | $0 |
| Dec 17, 2025 | Robbins Andrew R | President and CEO, Director | Tax withholding(F) | 367K | $39.45 | $14.5M |
| Dec 17, 2025 | Robbins Andrew R | President and CEO, Director | Grant(A) | 185K | — | $0 |
| Dec 17, 2025 | Robbins Andrew R | President and CEO, Director | Grant(A) | 840K | — | $0 |
| Dec 17, 2025 | Robbins Andrew R | President and CEO, Director | Grant(A) | 245K | — | $0 |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | Grant(A) | 50K | — | $0 |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | Tax withholding(F) | 140K | $39.45 | $5.5M |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | Grant(A) | 320K | — | $0 |
| Dec 17, 2025 | Robinson John Edward | Chief Scientific Officer | Grant(A) | 65K | — | $0 |
| Oct 1, 2025 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Jul 10, 2025 | Fairmount Funds Management LLC | Director | Buy(P) | 2.8M | $9.00 | $25.0M |
| Jul 1, 2025 | Ferrante Karen Jean | Director | Grant(A) | 3K | — | $0 |
| Jun 4, 2025 | Morris Arlene | Director | Grant(A) | 45K | — | $0 |
| Jun 4, 2025 | Harwin Peter Evan | Director | Grant(A) | 45K | — | $0 |
| Jun 4, 2025 | Shegog Todd | Director | Grant(A) | 45K | — | $0 |
| Jun 4, 2025 | Ros Matthew | Director | Grant(A) | 45K | — | $0 |
| Jun 4, 2025 | Cain Christopher W. | Director | Grant(A) | 45K | — | $0 |
| Jun 4, 2025 | Ferrante Karen Jean | Director | Grant(A) | 45K | — | $0 |
| Apr 1, 2025 | Ferrante Karen Jean | Director | Grant(A) | 4K | — | $0 |
| Jan 23, 2025 | Kearns Evan | Chief Legal Officer | Grant(A) | 230K | — | $0 |
| Jan 23, 2025 | Robbins Andrew R | President and CEO, Director | Grant(A) | 915K | — | $0 |
| Jan 23, 2025 | Sachs Jessica | Chief Medical Officer | Grant(A) | 270K | — | $0 |
| Jan 23, 2025 | Robinson John Edward | Chief Scientific Officer | Grant(A) | 270K | — | $0 |
| Jan 23, 2025 | Pinnow Cole | Chief Commercial Officer | Grant(A) | 240K | — | $0 |
| Jan 23, 2025 | Green John L. | Chief Financial Officer | Grant(A) | 270K | — | $0 |
| Jan 14, 2025 | Pinnow Cole | Chief Commercial Officer | Buy(P) | 44K | $7.60 | $333K |
| Jan 1, 2025 | Ferrante Karen Jean | Director | Grant(A) | 3K | — | $0 |
| Oct 1, 2024 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Jul 1, 2024 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Jun 10, 2024 | Fairmount Funds Management LLC | Director | Option exercise(M) | 1.5M | — | — |
| Jun 10, 2024 | Fairmount Funds Management LLC | Director | Option exercise(M) | 2K | — | $0 |
| Jun 5, 2024 | Morris Arlene | Director | Grant(A) | 45K | — | $0 |
| Jun 5, 2024 | Shegog Todd | Director | Grant(A) | 45K | — | $0 |
| Jun 5, 2024 | Harwin Peter Evan | Director | Grant(A) | 45K | — | $0 |
| Jun 5, 2024 | Ferrante Karen Jean | Director | Grant(A) | 45K | — | $0 |
| Jun 5, 2024 | Ros Matthew | Director | Grant(A) | 45K | — | $0 |
| Jun 5, 2024 | Cain Christopher W. | Director | Grant(A) | 45K | — | $0 |
| May 25, 2024 | Pinnow Cole | Chief Commercial Officer | Grant(A) | 525K | — | $0 |
| Apr 1, 2024 | Ferrante Karen Jean | Director | Grant(A) | 3K | — | $0 |
| Mar 28, 2024 | Fairmount Funds Management LLC | Director | Other(J) | 287K | — | — |
| Mar 28, 2024 | Fairmount Funds Management LLC | Director | Other(J) | 287K | — | — |
| Mar 28, 2024 | Fairmount Funds Management LLC | Director | Other(J) | 12K | — | $0 |
| Mar 28, 2024 | Fairmount Funds Management LLC | Director | Other(J) | 12K | — | $0 |
| Feb 16, 2024 | Fairmount Funds Management LLC | 10% Owner | Grant(A) | 1.2M | $7.50 | $8.7M |
| Feb 16, 2024 | Fairmount Funds Management LLC | 10% Owner | Grant(A) | 2K | $7,500.00 | $11.3M |
| Jan 23, 2024 | Green John L. | Chief Financial Officer | Grant(A) | 300K | — | $0 |
| Jan 23, 2024 | Robbins Andrew R | President and CEO, Director | Grant(A) | 1.1M | — | $0 |
| Jan 23, 2024 | Sachs Jessica | Chief Medical Officer | Grant(A) | 300K | — | $0 |
| Jan 23, 2024 | Kearns Evan | Chief Legal Officer | Grant(A) | 255K | — | $0 |
| Jan 23, 2024 | Robinson John Edward | Chief Scientific Officer | Grant(A) | 300K | — | $0 |
| Jan 2, 2024 | Ros Matthew | Director | Grant(A) | 3K | — | $0 |
| Jan 2, 2024 | Ferrante Karen Jean | Director | Grant(A) | 3K | — | $0 |
| Oct 2, 2023 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Oct 2, 2023 | Ros Matthew | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2023 | Ros Matthew | Director | Grant(A) | 2K | — | $0 |
| Jul 3, 2023 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Jun 9, 2023 | Fairmount Funds Management LLC | 10% Owner | Buy(P) | 800K | $12.00 | $9.6M |
| Jun 7, 2023 | Harwin Peter Evan | Director | Grant(A) | 37K | — | $0 |
| Jun 7, 2023 | Ros Matthew | Director | Grant(A) | 37K | — | $0 |
| Jun 7, 2023 | Shegog Todd | Director | Grant(A) | 37K | — | $0 |
| Jun 7, 2023 | Ferrante Karen Jean | Director | Grant(A) | 37K | — | $0 |
| Jun 7, 2023 | Cain Christopher W. | Director | Grant(A) | 37K | — | $0 |
| Jun 7, 2023 | Morris Arlene | Director | Grant(A) | 37K | — | $0 |
| Apr 3, 2023 | Ros Matthew | Director | Grant(A) | 2K | — | $0 |
| Apr 3, 2023 | Ferrante Karen Jean | Director | Grant(A) | 2K | — | $0 |
| Feb 13, 2023 | Robbins Andrew R | President and CEO, Director | Grant(A) | 525K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-03-29 → 2026-07-11. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).